US authorities on Monday lifted restrictions on the prescription and use of the anti-diabetes drug Avandia after a new study indicated it did not carry an elevated risk of heart attacks.
The US Food and Drug Administration (FDA) announced the decision after considering the recommendations made by a 26-member panel of experts on June 6.
“Our actions today reflect the most current scientific knowledge about the risks and benefits of this drug,” said Janet Woodcock, head of the FDA’s Center for Drug Evaluation and Research.
“Given these new results, our level of concern is considerably reduced; thus we are requiring the removal of certain prescribing restrictions,” she added.
The FDA move will include the removal of labeling which warns of a possible cardiovascular risk through taking the drug.
As soon as the changes are finalized the use of rosiglitazone (Avandia) will no longer be limited to use by certain patients, the FDA statement said.
The drug’s new indication will state that it may be used in conjunction with diet and exercise to improve control of blood sugar levels in patients with type 2 diabetes, similar to other diabetes drugs on the market.
The FDA slapped restrictions on Avandia in 2010, hitting sales of the drug manufactured by British firm GlaxoSmithKline.
Sales of Avandia started to slide in 2007 after researchers raised the possibility of a link between the drug and an increased cardiovascular risk based on clinical trial analyzes.
GlaxoSmithKline had insisted the drug — at one time the biggest-selling drug in the world with annual sales worth $3 billion — was completely safe.
[Image via Agence France-Presse]
China hits out at ‘bullying’ US over new tariffs
China on Saturday angrily hit out at the latest US tariff hikes on its goods, saying a "bullying" Washington would eventually "eat its own bitter fruit".
European leaders have also warned US President Donald Trump of the dangers of trade skirmishes with China and Europe, which look set to dominate the G7 summit due to begin in France.
Trump on Friday increased existing and planned tariffs on a total of $550 billion in Chinese goods, in response to new tit-for-tat levy hikes announced earlier that day by Beijing on $75 billion of US imports.
A Chinese commerce ministry spokesman on Saturday denounced Washington's "unilateral and bullying trade protectionism".
Mass rallies, crazy decisions, grandiose posturing: This is what living in a dictatorship feels like
Another week of shaking our heads and wondering how much longer we can survive him. Yet again, Donald Trump overwhelmed practically everything with the force of his obscene personality, running his mouth and his thumbs even while he was failing to run the country in any sort of conventional sense. He doesn’t actually do anything, but he dominates everything. Living in America today is like being trapped in a room with him — no doors, no windows, no exits, only Trump and the sound of Trump and the hideous image of Trump, all day, every day, for day after day after day.
This article first appeared in Salon.
Trump officials furious with NRA over ‘dick move’ leak of LaPierre phone call: report
President Donald Trump originally appeared interested in strengthening federal background check laws in the wake of deadly mass shootings in El Paso, Texas and Dayton, Ohio. Then, after a phone conversation with National Rifle Association CEO Wayne LaPierre on Tuesday, Trump reportedly assured him that background checks were "off the table" and pivoted to discussing anything but guns.
It was a depressingly familiar moment for Trump, who also previously headfaked toward some minor gun control reforms after the Parkland school shooting and quickly walked them back.